News and Announcements
MedAdvisor Signs Pfizer for Patient Engagement Program
- Published December 08, 2016 10:27AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
8th December 2016 – ASX Announcement
- MedAdvisor signs Pfizer, the world’s largest research-based pharmaceutical company to deliver a patient engagement program (PEP) on its platform
- Pfizer will use the MedAdvisor platform to deliver information and advice to patients to enhance and promote the safe and effective use of its medication
- Pfizer develops, manufactures and distributes hundreds of prescription medicines, vaccines and over-the-counter products
- Agreement with Pfizer and renewed programs provide strong validation of the value the PEPs are delivering pharmaceutical manufacturers and the Company’s ability to grow this revenue stream
MedAdvisor Limited (ASX: MDR, the Company), Australia’s leading digital medication adherence company, is pleased to announce that it has entered into an agreement with Pfizer Australia Pty Limited (Pfizer) to provide a Patient Engagement Program (PEP) for one of its leading medications.
MedAdvisor will work with Pfizer to deliver important information and guidance to patients prescribed with this Pfizer medication. Preparation for the program has already commenced and it will run for an initial period of 18 months.
To view the full announcement, please click on the button below.
Company Updates
BlackRock has named the next Economy. What this latest paper means for Private Market Investors.
BlackRock has put a name on something the smart money has been circling for two years. Its digital assets research team calls it the machine-native economy. The thesis fits in one line. AI is machine-native intelligence. Digital assets are machine-native money. Both are built on the same architecture, and they are converging into a single […]
Where’s the beef? Blackstone just answered the AI question.
In 1984, a fast food ad asked a question that became a catchphrase. Where’s the beef? Jon Gray, President of Blackstone, used that line this month in front of global LPs. It is the question every capital allocator is asking about AI. Trillions of dollars are going into chips, data centres and power. That is […]
The Best of Both Worlds: How Omnique Fund is Rewiring Real World Assets via Tokenisation
For decades, the playbook for Australia’s wholesale investors has remained relatively unchanged: pick between the slow-moving, illiquid reliability of tangible assets like property and gold, or chase the frictionless, high-velocity liquidity of public equity and digital markets. But as macroeconomic volatility spikes and a structural housing deficit reshapes private debt demand, sophisticated investors are demanding […]
Backed By Leading Investment Groups and Family Offices
